[1]
|
Ree, I., et al. (2017) Neonatal Management and Outcome in Alloimmune Hemolytic Disease. Expert Review of Hematol-ogy, 10, 607-616. https://doi.org/10.1080/17474086.2017.1331124
|
[2]
|
Jackson, M.E. and Baker, J.M. (2021) Hemolytic Disease of the Fetus and Newborn: Historical and Current State. Clinics in Laboratory Medicine, 41, 133-151. https://doi.org/10.1016/j.cll.2020.10.009
|
[3]
|
Myle, A.K. and Al-Khattabi, G.H. (2021) Hemolytic Disease of the Newborn: A Review of Current Trends and Prospects. Pediatric Health, Medicine and Therapeutics, 12, 491-498. https://doi.org/10.2147/PHMT.S327032
|
[4]
|
De Winter, D.P., et al. (2023) History and Current Standard of Post-natal Management in Hemolytic Disease of the Fetus and Newborn. European Journal of Pediatrics, 182, 489-500. https://doi.org/10.1007/s00431-022-04724-0
|
[5]
|
Morgan, J.M., Peters, S. and Adusei-Baah, C. (2023) Hemolytic Disease of the Newborn: A Community Hospitalist Perspective. Clinical Pediatrics, 62, 404-408. https://doi.org/10.1177/00099228221133175
|
[6]
|
de Winter, D.P., Kaminski, A., Tjoa, M.L., Oepkes, D. and Lo-priore, E. (2023) Hemolytic Disease of the Fetus and Newborn: Rapid Review of Postnatal Care and Outcomes. BMC Pregnancy and Childbirth, 23, Article No. 738.
https://doi.org/10.1186/s12884-023-06061-y
|
[7]
|
van T, O.R., et al. (2022) Identification and Management of Fetal Anemia Due to Hemolytic Disease. Expert Review of Hematology, 15, 987-998. https://doi.org/10.1080/17474086.2022.2138853
|
[8]
|
Dhabangi, A., et al. (2022) A Cross-Sectional Study of Haemolytic Disease of the Newborn in Uganda. Vox Sanguinis, 117, 1398-1404. https://doi.org/10.1111/vox.13376
|
[9]
|
Johnson, L. and Bhutani, V.K. (2011) The Clinical Syndrome of Biliru-bin-Induced Neurologic Dysfunction. Seminars in Perinatology, 35, 101-113. https://doi.org/10.1053/j.semperi.2011.02.003
|
[10]
|
Kemper, A.R., et al. (2022) Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics, 150, e2022058865. https://doi.org/10.1542/peds.2022-058865
|
[11]
|
Par, E.J., Hughes, C.A. and DeRico, P. (2023) Ne-onatal Hyperbilirubinemia: Evaluation and Treatment. American Family Physician, 107, 525-534.
|
[12]
|
Mohan, D.R., et al. (2023) Evaluation of Intravenous Immunoglobulin Administration for Hyperbilirubinemia in Newborn Infants with Hemolytic Disease. Children, 10, Article 496. https://doi.org/10.3390/children10030496
|
[13]
|
Vlachodimitropoulou, E., et al. (2023) Intravenous Immunoglobulin in the Management of Severe Early Onset Red Blood Cell Alloimmunisa-tion. British Journal of Haematology, 200, 100-106. https://doi.org/10.1111/bjh.18449
|
[14]
|
Stokowski, L.A. (2011) Fundamentals of Phototherapy for Neonatal Jaundice. Advances in Neonatal Care, 11, S10-S21.
https://doi.org/10.1097/ANC.0b013e31822ee62c
|
[15]
|
Woodgate, P. and Jardine, L.A. (2015) Neonatal Jaundice: Phototherapy. Clinical Evidence, 11, S10-S21.
|
[16]
|
Horn, D., Ehret, D., Gautham, K.S. and Soll, R. (2021) Sunlight for the Prevention and Treatment of Hyperbilirubinemia in Term and Late Preterm Neonates. Cochrane Database of System-atic Reviews, 7, CD013277.
https://doi.org/10.1002/14651858.CD013277.pub2
|
[17]
|
Van Rostenberghe, H., et al. (2020) Use of Reflective Materials during Phototherapy for Newborn Infants with Unconjugated Hyperbilirubinaemia. Cochrane Database of Systematic Reviews, 7, CD012011.
https://doi.org/10.1002/14651858.CD012011.pub2
|
[18]
|
Xiong, T., Qu, Y., Cambier, S. and Mu, D.Z. (2011) The Side Effects of Phototherapy for Neonatal Jaundice: What Do We Know? What Should We Do? European Journal of Pediatrics, 170, 1247-1255.
https://doi.org/10.1007/s00431-011-1454-1
|
[19]
|
Newman, T.B., et al. (2016) Retrospective Cohort Study of Pho-totherapy and Childhood Cancer in Northern California. Pediatrics, 137, e20151354. https://doi.org/10.1542/peds.2015-1354
|
[20]
|
Maayan-Metzger, A., Yosipovitch, G., Hadad, E. and Sirota, L. (2001) Transepidermal Water Loss and Skin Hydration in Preterm Infants during Phototherapy. American Journal of Perinatol-ogy, 18, 393-396.
https://doi.org/10.1055/s-2001-18698
|
[21]
|
Lai, N.M., et al. (2017) Fluid Supplementation for Neonatal Unconju-gated Hyperbilirubinaemia. Cochrane Database of Systematic Reviews, 8, CD011891. https://doi.org/10.1002/14651858.CD011891.pub2
|
[22]
|
Boo, N.Y. and Lee, H.T. (2002) Randomized Controlled Trial of Oral versus Intravenous Fluid Supplementation on Serum Bilirubin Level during Phototherapy of Term Infants with Severe Hyperbilirubinaemia. Journal of Paediatrics and Child Health, 38, 151-155. https://doi.org/10.1046/j.1440-1754.2002.00746.x
|
[23]
|
Mehta, S., Kumar, P. and Narang, A. (2005) A Random-ized Controlled Trial of Fluid Supplementation in Term Neonates with Severe Hyperbilirubinemia. The Journal of Pedi-atrics, 147, 781-785.
https://doi.org/10.1016/j.jpeds.2005.07.026
|
[24]
|
Vreman, H.J., Wong, R.J. and Stevenson, D.K. (2004) Photo-therapy: Current Methods and Future Directions. Seminars in Perinatology, 28, 326-333. https://doi.org/10.1053/j.semperi.2004.09.003
|
[25]
|
Diamond, L.K., Allen, F.J. and Thomas, W.J. (1951) Erythro-blastosis Fetalis—Treatment with Exchange Transfusion. The New England Journal of Medicine, 244, 39-49. https://doi.org/10.1056/NEJM195101112440201
|
[26]
|
Murki, S. and Kumar, P. (2011) Blood Exchange Transfu-sion for Infants with Severe Neonatal Hyperbilirubinemia. Seminars in Perinatology, 35, 175-184. https://doi.org/10.1053/j.semperi.2011.02.013
|
[27]
|
Steiner, L.A., et al. (2007) A Decline in the Frequency of Neo-natal Exchange Transfusions and Its Effect on Exchange-Related Morbidity and Mortality. Pediatrics, 120, 27-32. https://doi.org/10.1542/peds.2006-2910
|
[28]
|
Subcommittee on Hyperbilirubinemia (2004) Management of Hyper-bilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics, 114, 297-316. https://doi.org/10.1542/peds.114.1.297
|
[29]
|
Alsaleem, M. (2020) Intravenous Immune Globulin Uses in the Fetus and Neonate: A Review. Antibodies, 9, Article 60. https://doi.org/10.3390/antib9040060
|
[30]
|
Ballow, M. (2011) The IgG Molecule as a Biological Immune Response Modifier: Mechanisms of Action of Intravenous Immune Serum Globulin in Autoimmune and Inflammatory Disorders. Journal of Allergy and Clinical Immunology, 127, 315-323. https://doi.org/10.1016/j.jaci.2010.10.030
|
[31]
|
Huang, S., et al. (2020) The Improvement Effect of Different Doses of Gamma Globulin on the Disease Condition of Infants with Hemolytic Disease of Newborn and Their Effects on Im-mune Factors in Serum. Iranian Journal of Public Health, 49, 914-922. https://doi.org/10.18502/ijph.v49i5.3209
|
[32]
|
郑建珅. 大剂量静脉丙种球蛋白早期应用治疗新生儿溶血病的临床研究[J]. 实验与检验医学, 2022, 40(6): 730-732.
|
[33]
|
陈筱羽. 静脉注射免疫球蛋白治疗新生儿溶血病对肠道组织氧合的影响[D]: [博士学位论文]. 广州: 南方医科大学, 2020.
|
[34]
|
李德振. 大剂量丙种球蛋白治疗新生儿ABO溶血病的效果评价[J]. 临床医药文献电子杂志, 2020, 7(13): 48.
|
[35]
|
吴桂娥, 梁世山, 王琦凡. 大剂量丙种球蛋白治疗新生儿溶血症的临床疗效[J]. 临床合理用药杂志, 2019, 12(15): 67-68.
|
[36]
|
Okulu, E., et al. (2022) Intravenous Immunoglobulin Use in Hemolytic Disease Due to ABO Incompatibility to Prevent Exchange Transfusion. Frontiers in Pediatrics, 10, Article 864609. https://doi.org/10.3389/fped.2022.864609
|
[37]
|
Pan, J., et al. (2021) Intravenous Immunoglobulin G in the Treatment of ABO Hemolytic Disease of the Newborn during the Early Neonatal Period at a Tertiary Academic Hospital: A Retrospective Study. Journal of Perinatology, 41, 1397-1402. https://doi.org/10.1038/s41372-021-00963-5
|
[38]
|
Shahian, M. and Moslehi, M.A. (2010) Effect of Albumin Ad-ministration Prior to Exchange Transfusion in Term Neonates with Hyperbilirubinemia—A Randomized Controlled Trial. Indian Pediatrics, 47, 241-244.
https://doi.org/10.1007/s13312-010-0046-x
|
[39]
|
Dash, N., Kumar, P., Sundaram, V. and Attri, S.V. (2015) Pre Exchange Albumin Administration in Neonates with Hyperbilirubinemia: A Randomized Controlled Trial. Indian Pediat-rics, 52, 763-767.
https://doi.org/10.1007/s13312-015-0713-z
|
[40]
|
Kaabneh, M.A., et al. (2015) Phenobarbital and Phototherapy Combination Enhances Decline of Total Serum Bilirubin and May Decrease the Need for Blood Exchange Transfusion in Newborns with Isoimmune Hemolytic Disease. Clinical Medicine Insights: Pediatrics, 9, 67-72. https://doi.org/10.4137/CMPed.S24909
|
[41]
|
Trevett, T.J., Dorman, K., Lamvu, G. and Moise Jr., K.J. (2005) An-tenatal Maternal Administration of Phenobarbital for the Prevention of Exchange Transfusion in Neonates with Hemolytic Disease of the Fetus and Newborn. American Journal of Obstetrics & Gynecology, 192, 478-482. https://doi.org/10.1016/j.ajog.2004.08.016
|
[42]
|
Kappas, A., et al. (1988) Sn-Protoporphyrin Use in the Manage-ment of Hyperbilirubinemia in Term Newborns with Direct Coombs-Positive ABO Incompatibility. Pediatrics, 81, 485-497.
|
[43]
|
Valaes, T., et al. (1994) Control of Jaundice in Preterm Newborns by an Inhibitor of Bilirubin Production: Studies with Tin-Mesoporphyrin. Pediatrics, 93, 1-11. https://doi.org/10.1542/peds.93.1.1
|
[44]
|
Reddy, P., et al. (2003) Tin-Mesoporphyrin in the Treatment of Severe Hyperbilirubinemia in a Very-Low-Birth-Weight Infant. Journal of Perinatology, 23, 507-508. https://doi.org/10.1038/sj.jp.7210943
|
[45]
|
Dennery, P.A. (2005) Metalloporphyrins for the Treatment of Neonatal Jaundice. Current Opinion in Pediatrics, 17, 167-169. https://doi.org/10.1097/01.mop.0000156270.25640.5a
|
[46]
|
Méndez-Sánchez, N., Roldán-Valadez, E., Flores, M.A., Cárdenas-Vázquez, R. and Uribe, M. (2001) Zinc Salts Precipitate Unconjugated Bilirubin in vitro and Inhibit En-terohepatic Cycling of Bilirubin in Hamsters. European Journal of Clinical Investigation, 31, 773-780. https://doi.org/10.1046/j.1365-2362.2001.00879.x
|
[47]
|
Mishra, S., et al. (2015) Oral Zinc for the Prevention of Hyperbilirubinaemia in Neonates. Cochrane Database of Systematic Reviews, No. 7, CD008432. https://doi.org/10.1002/14651858.CD008432.pub2
|
[48]
|
Sharma, D., Farahbakhsh, N., Sharma, P. and Shastri, S. (2017) Role of Oral Zinc Supplementation for Reduction of Neonatal Hyperbilirubinemia: A Systematic Review of Cur-rent Evidence. The Journal of Maternal-Fetal & Neonatal Medicine, 30, 1953-1962. https://doi.org/10.1080/14767058.2016.1234600
|
[49]
|
Fallah, R., Islami, Z. and Lotfi, S.R. (2012) Single Dose of 50 mg/kg Clofibrate in Jaundice of Healthy Term Neonates: Randomised Clinical Trial of Efficacy and Safety. The Indian Journal of Pediatrics, 79, 194-197.
https://doi.org/10.1007/s12098-011-0531-9
|
[50]
|
梅涛, 李晓英, 张琳, 等. 益生菌预防新生儿ABO溶血并发新生儿坏死性小肠结肠炎的临床疗效分析[J]. 中国妇幼健康研究, 2021, 32(11): 1644-1648.
|